1. Market Research
  2. > Biotechnology
  3. > Biological Therapy Market Trends
  4. > Biological Therapy Analysis & Statistics, August 2016 (p20)

Biological Therapy Analysis & Statistics, August 2016 (p20)

24/7 Customer Support

Talk to Amrita

+1 718 303 2019

Publishers

571-600 of about 1000 reports

Purchase Reports From Reputable Market Research Publishers

T-Cell Leukemia Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

T-Cell Leukemia Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “T-Cell Leukemia Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Leukemia clinical ...

  • Industries : Cancer, Pathology
  • Countries : World

Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Natural Killer Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Cancer, Pathology
  • Countries : World, United States

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Multiple Myeloma (Kahler Disease) Global Clinical Trials Review, H2, 2016" provides ...

  • Industries : Drug Discovery and Development, Pharmaceutical
  • Countries : World, United States

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Transitional Cell Cancer (Urothelial Cell Cancer) Global Clinical ...

  • Industries : Cancer, Pathology, Therapy
  • Countries : World

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Peripheral Nerve Sheath Tumor (Neurofibrosarcoma) Global Clinical ...

  • Industries : Therapy, Biological Therapy, Pharmaceutical, Cancer, Pathology
  • Countries : World

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

T-Cell Lymphomas Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “T-Cell Lymphomas Global Clinical Trials Review, H2, 2016" provides an overview of T-Cell Lymphomas ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer, Pathology
  • Countries : World, United States

Bronchopulmonary Dysplasia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Bronchopulmonary Dysplasia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Bronchopulmonary Dysplasia - Pipeline Review, H2 2016’, provides an overview of the Bronchopulmonary Dysplasia ...

  • Industries : Therapy, Pharmaceutical, Chronic Disease
  • Countries : United States

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

N Sulphoglucosamine Sulphohydrolase (Sulfoglucosamine Sulfamidase or Sulphamidase or SGSH or EC 3.10.1.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘N Sulphoglucosamine Sulphohydrolase ...

  • Industries : Therapy, Pharmaceutical, Pathology
  • Countries : World, United States

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Juvenile Macular Degeneration (Stargardt Disease) - Pipeline Review, H2 2016’, provides ...

  • Industries : Pathology, Health Services, Healthcare
  • Countries : United States

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC 1.16.3.1) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Frataxin Mitochondrial (Friedreich Ataxia Protein or FXN or EC ...

  • Industries : Therapy, Pharmaceutical, Biological Therapy, Pathology
  • Countries : United States, World

Osteoarthritis - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Osteoarthritis - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Osteoarthritis - Pipeline Review, H2 2016’, provides an overview of the Osteoarthritis pipeline landscape. The report provides ...

  • Industries : Pathology, Chronic Disease
  • Countries : United States, World

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Glioblastoma Multiforme (GBM) Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Pharmaceutical, Cancer
  • Countries : World

3D Cell Culture Market Analysis By Technology, By Application,, By End Use And Segment Forecasts To 2024

  • $ 4950
  • Industry report
  • August 2016
  • by Grand View Research

The global 3D cell culture market is anticipated to reach USD 1.69 billion by 2024, according to a new report by Grand View Research, Inc. Potential of this technology to replace and reduce the usage of ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Drug Discovery and Development, Mental Health, Pathology, Pharmaceutical
  • Countries : World

Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016

  • $ 2500
  • Industry report
  • August 2016
  • by GlobalData

Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016 Summary GlobalData's clinical trial report, “Chronic Spinal Cord Injury Global Clinical Trials Review, H2, 2016" provides an overview ...

  • Industries : Mental Health, Pathology, Therapy
  • Countries : World

Cell Therapy - Industry Market Research Report

  • $ 1020
  • Industry report
  • August 2016
  • by Ibisworld

Generating growth: More funding for R&D will spur strong revenue gains Abstract Cell Therapy Although the Cell Therapy industry is a fast-growing industry, its companies operate at a loss due to the high ...

  • Industries : Biological Therapy
  • Countries : United States

Epstein-Barr Viral Infections - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Epstein-Barr Viral Infections - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Epstein-Barr Viral Infections - Pipeline Review, H2 2016’, provides an overview of the Epstein-Barr Viral ...

  • Industries : Pathology, Therapy, Pharmaceutical, Cancer
  • Countries : United States, World, United Kingdom

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • August 2016
  • by Global Markets Direct

Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 17 Receptor A (CDw217 or CD217 or IL17RA) - Pipeline Review, H2 2016’, ...

  • Industries : Biological Therapy, Therapy, Pharmaceutical
  • Countries : World, United States

Rosetta Genomics, Ltd. (ROSG) - Product Pipeline Analysis, 2016 Update

  • $ 750
  • Company report
  • August 2016
  • by GlobalData

Summary Rosetta Genomics Ltd (RGL) is a biotechnology company that develops next generation diagnostic tests for personalized medicine. The company offers testing services such as cancer origin, next-gen, ...

  • Industries : Cancer, Genomics
  • Countries : United States

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘B-Cell Chronic Lymphocytic Leukemia - Pipeline Review, H2 2016’, provides an overview of the B-Cell ...

  • Industries : Cancer, Pathology
  • Countries : United States

Crohn’s Disease (Regional Enteritis) - Pipeline Review, H2 2016

  • $ 2000
  • Company report
  • August 2016
  • by Global Markets Direct

Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Crohn's Disease (Regional Enteritis) - Pipeline Review, H2 2016’, provides an overview of the Crohn's ...

  • Industries : Pathology, Healthcare, Therapy
  • Countries : United States

RNAs (miRNA, RNAi & siRNA) in Oncology: Drug Pathway Analyzer

  • $ 750
  • Industry report
  • August 2016
  • by Bioseeker

Extra value: One year of free online updates included with this product There are today at least 102 RNA (miRNA, RNAi & siRNA) drugs known to affect more than 168 specific intracellular signaling pathways ...

  • Industries : Biological Therapy

Regenerative Medicine Market by technology, Material and Application - Global Opportunity Analysis and Industry Forecasts, 2014 - 2022

  • $ 3840
  • Industry report
  • August 2016
  • by Allied Market Research

Regenerative medicines hold the ability to replace, repair, and regenerate tissues and organs that are affected due to some disease, injury, or natural ageing process. These medicines are capable of restoring ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World

Regenerative Medicine Market: Global Industry Analysis and Opportunity Assessment, 2015-2019

  • $ 5000
  • Industry report
  • August 2016
  • by Future Market Insight Global & Consulting Pvt Ltd

REPORT DESCRIPTION This report analyzes the current and future prospects of the regenerative medicine across the globe. Regenerative medicine is considered as an emerging field of medical science that ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World

Global Market Study on 3D Cell Culture: Asia to Witness Highest Growth by 2020

  • $ 4900
  • Industry report
  • August 2016
  • by Persistence Market Research

3D cell culture is a man-made environment which is created to allow cells to grow and interact with the surroundings in all three dimensions. It is an advanced cell culture technique that overcomes limitations ...

  • Industries : Biological Therapy, In Vitro Diagnostics
  • Countries : World

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation

  • $ 6995
  • Industry report
  • August 2016
  • by GBI Research

Frontier Pharma: Rheumatoid Arthritis - Cytokine Mediators and Kinase Inhibitors Dominate First-in-Class Product Innovation Summary Rheumatoid Arthritis (RA) is a chronic, progressive and currently incurable ...

  • Industries : Pathology, Chronic Disease, Therapy, Biological Therapy
  • Countries : World

Global Regenerative Medicines Market - Size, Global Trends, Company Profiles, Demand, Insights, Analysis, Research, Report, Opportunities, Segmentation and Forecast, 2015 - 2022

  • $ 3840
  • Industry report
  • August 2016
  • by Allied Market Research

Regenerative medicines have the unique ability to repair, replace and regenerate tissues and organs, affected due to some injury, disease or due to natural aging process. These medicines are capable of ...

  • Industries : Biological Therapy, Biotechnology, Genomics
  • Countries : World

B-Cell Maturation Antigen (BCMA): hot target for emerging treatment modalities

  • $ 550
  • Industry report
  • August 2016
  • by La Merie Publishing

B-Cell Maturation Antigen (BCMA): hot target for emerging treatment modalities The highly restricted expression of B-cell maturation antigen (BCMA) to plasma cells and its role in the survival and ...

  • Industries : Biological Therapy, Therapy
  • Countries : United States

CD123: a paradigmatic target for immunotherapeutic treatment modalities

  • $ 770
  • Industry report
  • August 2016
  • by La Merie Publishing

CD123: a paradigmatic target for immunotherapeutic treatment modalities This report describes and evaluates the competitive landscape of CD123-targeted immunotherapeutics based on different treatment ...

  • Industries : Biological Therapy, Therapy
  • Countries : United States

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016

  • $ 3500
  • Company report
  • July 2016
  • by Global Markets Direct

Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016 Summary Global Markets Direct’s, ‘Interleukin 1 Beta (IL 1 Beta or Catabolin or IL1B) - Pipeline Review, H2 2016’, ...

  • Industries : Therapy, Pathology, Pharmaceutical, Biological Therapy, Chronic Disease
  • Countries : United States

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.